These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21788962)

  • 21. Aspirin in stroke prevention in nonvalvular atrial fibrillation and stable vascular disease: an era of new anticoagulants.
    Turagam MK; Velagapudi P; Leal MA; Kocheril AG
    Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):433-9. PubMed ID: 22458577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Warfarin for atrial fibrillation: the end of an era?
    Donnan GA; Dewey HM; Chambers BR
    Lancet Neurol; 2004 May; 3(5):305-8. PubMed ID: 15099545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimising stroke prevention in non-valvular atrial fibrillation.
    Ederhy S; Cohen A
    Expert Opin Pharmacother; 2006 Oct; 7(15):2079-94. PubMed ID: 17020434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preventing cerebrovascular accidents during atrial fibrillation].
    Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
    Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clopidogrel hydrogen sulphate for atrial fibrillation.
    Garg N; Rajpurohit N; Flaker G
    Expert Opin Pharmacother; 2011 Aug; 12(11):1781-7. PubMed ID: 21663525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
    Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
    Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anticoagulation and antiaggregation in cardiac patients].
    Meyer BJ
    Ther Umsch; 2003 Jan; 60(1):27-32. PubMed ID: 12638475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
    Shah R; Hellkamp A; Lokhnygina Y; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Fox KA; Nessel CC; Mahaffey KW; Piccini JP; Singer DE; Patel MR;
    Am Heart J; 2016 Sep; 179():77-86. PubMed ID: 27595682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.
    Dzeshka MS; Lip GY
    Heart Fail Clin; 2016 Apr; 12(2):257-71. PubMed ID: 26968670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke prevention in atrial fibrillation: current anticoagulation management and future directions.
    Fitzgerald BT; Cohn SL; Klein AL
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S24-30. PubMed ID: 15853176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation and stroke prevention.
    Lip GY; Lim HS
    Lancet Neurol; 2007 Nov; 6(11):981-93. PubMed ID: 17945152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for stroke prevention in patients with atrial fibrillation.
    Howard PA
    Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Which antithrombotic treatment should be used in the treatment of an elderly patient with chronic atrial fibrillation?].
    Mahé I; Grenard AS; Caulin C; Bergmann JF
    Presse Med; 2003 Jul; 32(25):1170-4. PubMed ID: 13677880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB
    Cochrane Database Syst Rev; 2001; (1):CD001938. PubMed ID: 11279741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.